Issue 69, 2023

Galectin-targeting glycocalix[4]arenes can enter the cells

Abstract

Elevated levels of galectin-3 are associated with tumorigenesis. Its inhibition with high-affinity carbohydrate ligands opens new therapeutic routes. Targeting of intracellular galectin-3 is challenging for polar inhibitors like carbohydrates. We demonstrate the potential of novel biomedical research tools, glycocalix[4]arenes, to enter epithelial cells, which may allow their interaction with galectin-3.

Graphical abstract: Galectin-targeting glycocalix[4]arenes can enter the cells

Supplementary files

Article information

Article type
Communication
Submitted
16 Jun 2023
Accepted
30 Jul 2023
First published
31 Jul 2023

Chem. Commun., 2023,59, 10404-10407

Galectin-targeting glycocalix[4]arenes can enter the cells

M. Vlachová, V. N. Tran, J. Červený, F. Dolníček, L. Petrásková, H. Pelantová, O. Kundrát, J. Cvačka, Z. Bosáková, V. Křen, P. Lhoták, J. Viktorová and P. Bojarová, Chem. Commun., 2023, 59, 10404 DOI: 10.1039/D3CC02905K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements